Recall of Device Recall Atlantis(r) SR Pro 2, 40 MHz Coronary Imaging Catheter

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Boston Scientific Corporation.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    58405
  • Event Risk Class
    Class 1
  • Event Number
    Z-2418-2011
  • Event Initiated Date
    2011-03-28
  • Event Date Posted
    2011-06-10
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2012-07-30
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Catheter, intravascular, diagnostic - Product Code DQO
  • Reason
    Catheter tip detachment that is not associated with elongation of the catheter typically caused by excessive pulling forces. expanded: boston scientific is initiating a recall of all icross coronary imaging catheters because they have received and confirmed 8 occurrences of catheter tip detachments due to embrittlement.
  • Action
    Boston Scientific " Important Customer Notification" letters dated March 14, 2011 were hand delivered to customers by Boston Scientific sales representatives starting on March 28th, 2011. The sales representatives verbally reviewed information. A tracking log will be maintained document completion of the customer notifications. The letter described the product, problem and possible root cause as well as one corrective action, a change in sterilization method from Gamma to E-beam implementation. Boston Scientific sent an Urgent Medical Device Recall Removal - Immediate Action Required letter dated May 26, 2011, to all affected customers. Customers were instructed to Identify and discontinue use of any affected product within their inventory and to segregate it immediately and return it to Boston Scientific

Device

  • Model / Serial
    All lots are impacted. 13478001, 13479862, 13483687, 13483794, 13486679, 13488281, 13492691, 13495381, 13495537, 13501702, 13509959, 13510363, 13510388, 13510970, 13513269, 13513370, 13518405, 13522499, 13525880, 13526246, 13529890, 13532559, 13532599, 13534080, 13537206, 13537450, 13541221, 13542989, 13543371, 13543372, 13543373, 13543374, 13543903, 13544086, 13548035, 13550071, 13551639, 13555107, 13557249, 13558528, 13560226, 13561192, 13561925, 13565449, 13572049, 13575534, 13576371, 13582549, 13587068, 13589401, 13591521, 13595076, 13598770, 13602027, 13604910, 13605911, 13607907, 13612369, 13613621, 13616694, 13617441, 13620814, 13623271, 13625428, 13627096, 13627610, 13628377, 13628378, 13628480, 13642454, 13644574, 13645440, 13648480, 13649064, 13649555, 13651806, 13659069, 13660352, 13663881, 13666991, 13670858, 13671958, 13675335, 13677173, 13679538, 13681808, 13685028, 13692281, 13711461, 13717161, 13721872, 13726417, 13729970, 13733692, 13736433, 13738543, 13744275, 13748118, 13751320, 13753544, 13755722, 13763259, 13766230, 13770525, 13772349, 13774311, 13779785, 13790510, 13795482, 13796520, 13799042, 13803863, 13807009, 13807405, 13810319, 13811040, 13813370, 13817138, 13823987, 13827155, 13828363, 13830503, 13834945, 13837411, 13846140, 13862022, 13866829, 13867763, 13867812, 13869465, 13871530, 13874961, 13874989, 13878848, 13881217, 13881902, 13883719, 13886293, 13889336, 13889690, 13892663, 13893369, 13897082, 13900781, 13906150, 13908756, 13909098, 13909550, 13909967, 13912695, 13913663, 13915857, 13916951, 13916953, 13920105, 13920710, 13920803, 13920805, 13921106, 13923537, 13924672, 13927066, 13928293, 13930289, 13932251, 13932695, 13935416, 13935514, 13936063, 13938497, 13938680, 13940859, 13943943, 13947364, 13950149, 13960559, 13964584, 13967316, 13970980, 13977845, 13982090, 13987794, 13990244, 13994171, 13997365, 14001705, 14006979, 14023919, 14032268, 14036676, 14038052, 14043294, 14048150, 14052253, 14054270, 14057246, 14059185, 14060218, 14060730, 14063990, 14064764, 14068345, 14071841, 14075967, 14075968, 14080311, 14081712, 14083655, 14086847, 14090453, 14090833, 14094058, 14098066, 14099289, 14101324, 14102725, 14105453, 14106322, 14109716, 14109807, 14113183, 14117941, 14125549, 14137883, 14140518, 14144461, 14147692, 14154145, 14156848, 14162309, 14164380, 14165091, 14167666, 14179509, 14183540, 14186298, 14191171, 14194753, 14198644, 14202609, 14203395, 14206342, 14206443, 14209358, 14210282, 14217182, 14219362, 14219394, 14226258, 14230360, 14235075, 14238057, 14239219, 14253978, 14255111, 14256086, 14256852, 14257870, 14258124, 14258292, 14260466, 14262256, 14267351, 14272686, 14272726, 14274123, 14275822, 14276666, 14278698, 14279887, 14280587, 14283635, 14285242, 14287832, 14289523.
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Worldwide Distribution - USA (nationwide) and Puerto Rico and the countries of Japan, Trinidad, Tobago, and American Virgin Islands.
  • Product Description
    Boston Scientific iCross, 40 MHz Coronary Imaging Catheter, 3.6F (1.18mm) x 135 cm, REF / Catalog No. 51805, UPN / Product No. H749518050, Sterilized using irradiation, Made in USA 47900 Bayside Parkway, Fremont, CA 94538 || This catheter is intended for ultrasound examination of coronary intravascular pathology only. Intravascular Ultrasound imaging is indicated in patients who are candidates for transluminal coronary interventional procedures.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Boston Scientific Corporation, 1 Scimed Pl, Maple Grove MN 55311-1565
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    USFDA